Diabetes therapy does not raise risk of breast cancer
Lockyer, M.
Practitioner 260(1798): 10
2016
ISSN/ISBN: 0032-6518 PMID: 28968049 Document Number: 686729
Document emailed within 1 workday
Related Documents
Lipkus, I.M.; Iden, D.; Terrenoire, J.; Feaganes, J.R. 1999: Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 8(6): 533-539Ichida, M.; Kataoka, A.; Tsushima, R.; Taguchi, T. 2015: No increase in breast cancer risk in Japanese women taking oral contraceptives: a case-control study investigating reproductive, menstrual and familial risk factors for breast cancer Asian Pacific Journal of Cancer Prevention: Apjcp 16(9): 3685-3690
Kuhl, C.K. 2002: High-risk screening: multi-modality surveillance of women at high risk for breast cancer (proven or suspected carriers of a breast cancer susceptibility gene) Journal of Experimental and Clinical Cancer Research: Cr 21(3 Suppl): 103-106
Chen, F.-P. 2009: Postmenopausal hormone therapy and risk of breast cancer Chang Gung Medical Journal 32(2): 140-147
1989: Cancer of the opposite breast: what risk from radiation therapy? Oncology 3(4): 22-25
Klitsch, M. 2002: Long-Term Pill Use, High Parity Raise Cervical Cancer Risk among Women with Human Papillomavirus Infection International Family Planning Perspectives 28(3): 176-177
Pinkerton, J.V.; Wilson, C.S.; Kaunitz, A.M. 2022: Reassuring data regarding the use of hormone therapy at menopause and risk of breast cancer Menopause 29(9): 1001-1004
Bershteĭn, L.M.; Boriakina, M.P.; Turkevich, E.A.; Tsyrlina, E.V.; Semiglazov, V.F. 2010: Effect of previous diabetes therapy on tumor receptor phenotype in breast cancer: comparison of metformin and sulphonylurea derivatives Voprosy Onkologii 56(3): 312-316
Santen, R.J.; Pinkerton, J.; McCartney, C.; Petroni, G.R. 2001: Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy Journal of Clinical Endocrinology and Metabolism 86(1): 16-23
Ruan, X.; Seeger, H.; Mueck, A.O. 2012: Breast cancer risk during hormone therapy: experimental versus clinical data Minerva Endocrinologica 37(1): 59-74
Ratanawichitrasin, A.; Reansuwan, W.; Ratanawichitrasin, S.; Bhodhisuwan, K.; Kongpatanakul, S. 2002: Risk of breast cancer in post-menopausal women using hormone replacement therapy Journal of the Medical Association of Thailand 85(5): 583-589
Chahine, G.; Howayek, M.; Atallah, D. 2009: Adjuvant endocrine therapy in breast cancer. Management of early-risk relapse Le Journal Medical Libanais. Lebanese Medical Journal 57(2): 124-129
Magnusson, C.; Weiderpass, E. 2001: Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer Lakartidningen 98(5): 418-421
Overgaard, M. 2000: Evaluation of radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy Rays 25(3): 325-330
Abe, R.; Tsuchiya, A.; Koie, H.; Ono, K.; Abo, S.; Saito, K.; Tsukamoto, M.; Sato, T.; Mori, S.; Motoki, R. 1988: Cooperative research on post-operative adjuvant therapy of breast cancer. Tohoku Society of Adjuvant Chemo-endocrine Therapy of Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(9): 2707-2712
2002: New SBU-report on estrogen replacement therapy in climacteric. Moderate risk of breast cancer after long-term use Lakartidningen 99(28-29): 3031-3034
Reiner, A.S.; Sisti, J.; John, E.M.; Lynch, C.F.; Brooks, J.D.; Mellemkjær, L.; Boice, J.D.; Knight, J.A.; Concannon, P.; Capanu, M.; Tischkowitz, M.; Robson, M.; Liang, X.; Woods, M.; Conti, D.V.; Duggan, D.; Shore, R.; Stram, D.O.; Thomas, D.C.; Malone, K.E.; Bernstein, L.; Bernstein, J.L. 2018: Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 36(15): 1513-1520
Soerjomataram, I.; Pukkala, E.; Brenner, H.; Coebergh, J.Willem.W. 2008: On the avoidability of breast cancer in industrialized societies: older mean age at first birth as an indicator of excess breast cancer risk Breast Cancer Research and Treatment 111(2): 297-302
Bethea, T.N.; Rosenberg, L.; Hong, C-Chen.; Troester, M.A.; Lunetta, K.L.; Bandera, E.V.; Schedin, P.; Kolonel, L.N.; Olshan, A.F.; Ambrosone, C.B.; Palmer, J.R. 2015: A case-control analysis of oral contraceptive use and breast cancer subtypes in the African American Breast Cancer Epidemiology and Risk Consortium Breast cancer research: BCR 17: 22
Metz, J.M.; Schultz, D.J.; Fox, K.; Mathews, A.; Glick, J.; Solin, L.J. 2000: Analysis of outcomes for high-risk breast cancer based on interval from surgery to postmastectomy radiation therapy Cancer Journal 6(5): 324-330